Rating History for Arbutus Biopharma (ABUS) by Jefferies
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/2/2022 | Dennis Ding | Upgrade | Buy (Hold) |
5.00 (4.00) |
2.81 (4.35) |
54.8% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/2/2022 | Dennis Ding | Upgrade | Buy (Hold) |
5.00 (4.00) |
2.81 (4.35) |
54.8% | Details |
![]() |
|||||||
![]() |
|||||||